| Primary |
| Drug Use For Unknown Indication |
24.6% |
| Skin Infection |
17.5% |
| Product Used For Unknown Indication |
6.0% |
| Rash |
6.0% |
| Staphylococcal Infection |
6.0% |
| Nasal Dryness |
4.4% |
| Prophylaxis |
3.8% |
| Rhinitis |
3.8% |
| Wound |
3.8% |
| Impetigo |
3.3% |
| Infection |
3.3% |
| Eczema |
2.7% |
| Bacterial Infection |
2.2% |
| Folliculitis |
2.2% |
| Sinus Disorder |
2.2% |
| Arthropod Bite |
1.6% |
| Cellulitis |
1.6% |
| Pulmonary Arterial Hypertension |
1.6% |
| Skin Lesion |
1.6% |
| Skin Ulcer |
1.6% |
|
| Drug Ineffective |
28.8% |
| Rash |
9.9% |
| Rhinalgia |
5.4% |
| Skin Burning Sensation |
5.4% |
| Pruritus |
4.5% |
| Erythema |
3.6% |
| Nasal Discomfort |
3.6% |
| Pain |
3.6% |
| Swelling |
3.6% |
| Therapeutic Response Unexpected |
3.6% |
| Urticaria |
3.6% |
| Blister |
2.7% |
| Burning Sensation |
2.7% |
| Hypersensitivity |
2.7% |
| Oropharyngeal Pain |
2.7% |
| Parosmia |
2.7% |
| Product Quality Issue |
2.7% |
| Rash Generalised |
2.7% |
| Rash Pruritic |
2.7% |
| Sinusitis |
2.7% |
|
| Secondary |
| Drug Use For Unknown Indication |
51.9% |
| Product Used For Unknown Indication |
21.9% |
| Vertigo |
6.2% |
| Pruritus |
3.1% |
| Skin Ulcer |
3.1% |
| Hypertension |
2.5% |
| Impetigo |
1.9% |
| Bacterial Infection |
1.5% |
| Cellulitis |
1.5% |
| Chemical Injury |
1.2% |
| Infection |
0.9% |
| Skin Infection |
0.9% |
| Muscle Spasms |
0.6% |
| Nasal Congestion |
0.6% |
| Sinusitis |
0.6% |
| Acute Sinusitis |
0.3% |
| Alopecia |
0.3% |
| Angina Pectoris |
0.3% |
| Arthritis |
0.3% |
| Glaucoma |
0.3% |
|
| Toxic Epidermal Necrolysis |
35.6% |
| Drug Ineffective |
20.0% |
| Ulcer |
4.4% |
| Upper Limb Fracture |
4.4% |
| Acrodermatitis |
2.2% |
| Blood Cholesterol Increased |
2.2% |
| Cataract |
2.2% |
| Chemical Injury |
2.2% |
| Death |
2.2% |
| Dermatitis Atopic |
2.2% |
| Dyspnoea |
2.2% |
| Folliculitis |
2.2% |
| Gastric Disorder |
2.2% |
| Infection |
2.2% |
| Insomnia |
2.2% |
| International Normalised Ratio Increased |
2.2% |
| Nasal Discomfort |
2.2% |
| Nasal Septum Perforation |
2.2% |
| Off Label Use |
2.2% |
| Pain |
2.2% |
|
| Concomitant |
| Drug Use For Unknown Indication |
28.3% |
| Product Used For Unknown Indication |
22.0% |
| Prophylaxis |
7.8% |
| Pain |
6.1% |
| Hypertension |
3.8% |
| Nausea |
3.3% |
| Constipation |
3.0% |
| Acne |
2.6% |
| Depression |
2.6% |
| Crohn's Disease |
2.4% |
| Dyspepsia |
2.3% |
| Diabetes Mellitus |
2.2% |
| Vomiting |
2.1% |
| Rheumatoid Arthritis |
1.9% |
| Anxiety |
1.7% |
| Hepatic Neoplasm Malignant |
1.7% |
| Gastrooesophageal Reflux Disease |
1.6% |
| Rash |
1.6% |
| Decreased Appetite |
1.5% |
| Arthralgia |
1.5% |
|
| Vomiting |
17.9% |
| Weight Decreased |
10.8% |
| Death |
7.8% |
| Xerosis |
6.0% |
| Pain |
5.2% |
| Proctitis |
4.9% |
| Rash |
4.9% |
| Arthralgia |
3.7% |
| Crohn's Disease |
3.4% |
| Pyrexia |
3.4% |
| Rectal Ulcer |
3.4% |
| Unresponsive To Stimuli |
3.4% |
| Vitreous Haemorrhage |
3.4% |
| Weight Increased |
3.4% |
| White Blood Cell Count Increased |
3.4% |
| Wound Infection Staphylococcal |
3.4% |
| Pneumonia |
3.0% |
| Postoperative Wound Infection |
3.0% |
| Respiratory Failure |
3.0% |
| Syncope |
3.0% |
|
| Interacting |
| Vertigo |
40.0% |
| Pruritus |
20.0% |
| Skin Ulcer |
20.0% |
| Sleep Disorder |
20.0% |
|
|
